The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 Presidents Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 Presidents Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Trial Academy Master Class 6.0
    • The Business Of Law
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

1,077 Mass Tort Cases Filed Over Hypertension Drug Benicar

Posted on November 18, 2015 by Larry Bodine

SKO0104ZAs of mid-October, there were 1,077 mass tort cases filed over hypertension drug Benicar within a Benicar MDL 2606 docket in New Jersey, where discovery has begun. The medication causes severe gastrointestinal symptoms among consumers.

The litigation not only involves Benicar, but also Benicar HCT, Azor, and Tribenzor, which have severe side effects. Daiichi Sankyo manufactures all four drugs. Benicar, also called Olmestaran received FDA approval in 2002, for treating high blood pressure. FDA approval for the remaining drugs followed.

Olmestaran is the active ingredient in the four medications marketed by Daiichi. 

Benicar Side Effects

 The controversial medication causes users to experience severe side effects. Consumers experienced massive diarrhea, nausea, vomiting, dehydration, malnutrition, and excessive weight loss.

See Also: Acquiring Mass Tort Cases with Sentinel Group and US Legal’s Strategic Partnership

These side effects are associated with a condition called Olmesartan Induced Enteropathy, which causes the gastrointestinal issues listed above. Enteropathy is a disease of the small intestine.

The medication essentially prevents the small intestines from absorbing nutrients from food. Some patients began experiencing these symptoms within 4-6 months after starting the new regimen. The symptoms last for as long as the patient continues taking the medication. Continued use causes long-term intestinal issues.

According to a Mayo Clinic article –joined by several physicians—after completing a small study of 22 patients, the patients experienced chronic diarrhea and weight loss, and 63 percent or 14 patients were hospitalized. Some patients were misdiagnosed with celiac disease or some other intestinal ailment. Most physicians did not consider medication as the cause of the ailments.

Benicar & FDA Label Changes

Two years ago, the FDA issued a safety announcement advising the effects of taking Benicar.

Specifically, the communication stated “the enteropathy may develop months to years after starting olmestran and sometimes causes hospitalization . . . the sprue-like enteropathy has not been detected with ARB drugs other than Olmesartan.”

The FDA simultaneously approved warning labels for the medications to be changed, to include adequate warnings for medical providers and consumers.

This announcement prompted additional research on the issue within the medical community.

DOJ Action over Bribes

In addition to the pending cases, the Department Of Justice recently reached a $39 million settlement with Daiichi Sankyo, to settle charges that it illegally committed Medicare fraud and violated the False Claims Act for giving kickbacks to doctors who prescribed Benicar and similar medications.

Generally, when new pharmaceuticals are approved, a sales representative’s task is to educate medical providers on the changes in medical science. However, the reality is to persuade doctors to administer their drugs. In the DOJ case, doctors were taken to expensive dinners, paid for speaking engagements, and tickets.

Other lawsuits claim that Daiichi knew or should have known about the risk associated with the drugs for years and withheld the information from consumers and the medical community.

Posted in Blog, Class Actions, Mass Torts

Comments are closed.

News Categories

Read about other Top Jury Verdicts

Defrauded College Students Will Have $6 Billion Forgiven in a New Settlement

Defrauded College Students Will Have $6 Billion Forgiven in a New Settlement

The Biden administration has agreed to cancel $6 billion in student loans for about 200,000 former students who say they were[Read More...]
An Iowa City Settles Lawsuit Over a Deadly Police Shooting For $5 Million

An Iowa City Settles Lawsuit Over a Deadly Police Shooting For $5 Million

Burlington, Iowa, has agreed to pay $5 million to settle a wrongful death lawsuit brought by the mother of a man who was shot[Read More...]
Co-Owners File a $695 Million Lawsuit Against Georgia Power Over a Contract Dispute

Co-Owners File a $695 Million Lawsuit Against Georgia Power Over a Contract Dispute

The owners of a majority share of a nuclear power plant being expanded in Georgia are suing lead owner Georgia Power Co., cla[Read More...]
A Tesla Worker Rejects a $15 Million Race Bias Settlement

A Tesla Worker Rejects a $15 Million Race Bias Settlement

A Black former elevator operator at Tesla Inc's flagship California assembly plant on Tuesday rejected a $15 million award in[Read More...]
Juneteenth Freedom Day

Juneteenth Freedom Day

History Prior to Juneteenth African tribe members were kidnapped, sold into slavery in the American colonies, and exp[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.